Compositions and methods for the treatment of hemoglobinopathies
- 专利权人:
- Novartis AG;Intellia Therapeutics, Inc.
- 发明人:
- Mickanin, Craig Stephen,Schmedt, Christian,Snead, Jennifer,Stevenson, Susan C.,Yang, Yi
- 申请号：
- AU2018215726
- 公开号：
- AU2018215726A1
- 申请日:
- 2018.02.05
- 申请国别(地区):
- AU
- 年份:
- 2019
- 代理人:
- 摘要：
- The present invention is directed to genome editing systems, reagents and methods for the treatment of hemoglobinopathies.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
- COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT D'HÉMOGLOBINOSES
- COMPOSITIONS ET METHODES POUR LE TRAITEMENT D'HEMOGLOBINOSES
- COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
- COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
